Status:
COMPLETED
Effectiveness of Bryophyllum in Nocturia-Therapy
Lead Sponsor:
University of Zurich
Conditions:
Nocturia
Sleep Disorder
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Night-time micturition, called nocturia, is a very common problem that unfavourably influences sleep- and life-qualities. The International Continence Society (ICS) defines nocturia as micturition onc...
Detailed Description
In the therapeutic concept of the treatment of OAB, antimuscarinic drugs play a central role. Antimuscarinics are known to inhibit the contraction of detrusor muscle (smooth muscle cells) and block th...
Eligibility Criteria
Inclusion
- Nocturia ≥2 Mal per a night
- Overactive bladder (\>8 Mictions/day)
- Age \> 18 Years
- local or systemic Therapy with Estrogen, if the therapy dates \>4 Weeks before study-start.
- prior incontinence operation (if the operation dates back more than 6 months)
- german speaking Patients and a given informed consent
Exclusion
- Intolerance against a substance or a compound
- participation in an other study 4 weeks prior to inclusion
- urinary tract infection
- drug abuse
- bladder affecting drugs like anticholinergics, diuretics, muscle relaxing medicaments and phytotherapeutics
- lactose intolerance
- Pregnant and lactating women
- Incompliance of Patient
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04480658
Start Date
January 1 2018
End Date
January 14 2022
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hospital, Clinic for Gynecology
Zurich, Switzerland, 8091